Business

<< Previous   of   Next >>   ADVERTISEMENT   Related Stories • Sonus Pharmaceuticals says it will appeal Nasdaq delisting 5/10/08 • Snohomish County firms' stock tumbles 4/1/08 • Bothell biotech Sonus trims costs, looks for partner 3/26/08 • Seattle Genetics grows with other biotechs struggle 3/17/08   CONTACT THE HERALD Mike Benbow, Business Editor benbow@heraldnet.com   Published: Wednesday, May 28, 2008 Sonus to merge with Canadian biotech Herald Staff BOTHELL - Sonus Pharmaceuticals Inc. announced this morning it will merge with Vancouver, B.C.-based OncoGenex Technologies Inc., a privately held biopharmaceutical company. Sonus’ stock was down 11 percent, or about 4 cents, as of mid-morning. Scott Cormack, OncoGenex’ president and chief executive officer, will lead the combined company. It was unclear this morning what role Michael Martino, Sonus’ longtime CEO, will have in the new biotechnology firm. Sonus had been looking at mergers or another way to rebuild after seeing the company’s value and revenue plummet when its lead cancer drug candidate failed in late-stage clinical trials last fall. A lucrative drug development partnership with Bayer Schering fell apart as a result. In the aftermath, Sonus' shares plummeted more than 90 percent. Sonus ended up cutting its staff down to about two dozen people. The newly combined company will have three cancer drug candidates in various stages of clinical development, including one candidate in phase 2 trials. "In October 2007, Sonus outlined its strategy to rebuild shareholder value," Martino said in a written statement. "We believe that this transaction represents an outstanding value creation opportunity for shareholders." Under the terms of the proposed merger, OncoGenex' stock holders will receive approximately 37 million shares of Sonus stock, and OncoGenex will become a wholly owned subsidiary of Sonus Pharmaceuticals Inc. Following the close of the proposed transaction, OncoGenex stockholders will hold 50 percent of Sonus' shares. While the boards of both companies approved the transaction, it still needs final approvals.

1. Man arrested in fatal shooting of brother 2. Highway 9 crash victims memorialized 3. Taxes needed to close state's growing deficit? 4. Confrontation led to elderly man's death, police say 5. Fire sends shoppers fleeing JC Penney at Alderwood 6. Snohomish salon owner has a venture with style 7. Pearl Harbor's voices of the past 8. Vikings’ Henderson breaks leg against Cardinals 9. Boeing shares soar as 787 first flight draws near 10. New law aims to deny some felons bail 2 - Top 10 Stories Most Talked about 3 - Top 10 Stories Most Emailed

• Wildcats fall to familar foe in semis • ‘Nutcracker' times three • Road warrior • Mavericks reloading • Holiday Lightings & Santa Sightings • Cities prepare for winter blast repeat • Wolfpack duo takes last shot at state tourney • This Weekend in Your Town • Tips for the stormy season • Boeing will build, flight test and deliver 787s in South Carolina to spe ... • Snohomish County EDC promoting job growth in key industry clusters • $4 million grant to advance brain tumor research has Everett links • Providence medical center construction tops off its 12-story steel frame ... • Tulalip affordable housing project to be financed by KeyBank, Raymond Ja ... • Arlington's Lak of Ink has a growing following for Luke Kooyman's creati ... • Bank of the Northwest formed • Cascade Bank earns $1.6 million